| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.05B | +0.6% |
| Cost of Revenue | $2.79B | +3.0% |
| R&D Expense | $178.9M | -5.5% |
| SG&A Expense | $350.7M | -5.4% |
| Operating Income | $181.7M | -72.9% |
| Interest Expense | $182.2M | -6.8% |
| Pre-tax Income | $17.8M | -95.5% |
| Income Tax | $21.8M | -74.7% |
| Net Income | -$3.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $508.1M | -58.5% |
| Accounts Receivable | $744.1M | +0.2% |
| Inventory | $713.5M | +10.6% |
| Current Assets | $2.10B | -24.2% |
| Total Assets | $7.68B | -12.3% |
| Current Liabilities | $823.7M | -30.1% |
| Long-term Debt | $3.40B | -19.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $456.7M | -0.9% |
| Investing Cash Flow | -$165.0M | +72.1% |
| Financing Cash Flow | -$1.02B | -187.6% |
| -101.3% |
| EPS (Basic) | -$0.03 | -101.5% |
| EPS (Diluted) | -$0.03 | -101.5% |
| Total Liabilities |
| $4.68B |
| -17.0% |
| Stockholders' Equity | $3.00B | -3.7% |